BackOrtho Clinical Diagnostics Holdings plc Overview

Ortho Clinical Diagnostics Holdings plc Research & Development

Get informed when a big investor buys or sells

+ Follow

Quarterly R&D Expenses

$32.20M
11.42% YoY

As of Apr 3, 2022

Annual R&D Expenses (TTM)

$129.50M
9.56% YoY

Trailing 12 months ending Apr 3, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Ortho Clinical Diagnostics Holdings plc (OCDX) FAQ

Stockcircle tracks research & development for Ortho Clinical Diagnostics Holdings plc (OCDX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Research & Development page is built for Ortho Clinical Diagnostics Holdings plc's historical R&D spending trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use R&D spending as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main OCDX overview so you can move from this figure to the surrounding analysis quickly.